INS and infection: The impact of SARS-CoV-2 on pathways that drive insulin resistance has been described, and this may explain the raised insulin requirements in the acute phase of the infection by SARS-CoV-2 and why this may fall as the infection resolves with subsequent clinical improvement [30, 31].